UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000012101
Receipt No. R000014136
Scientific Title Allergic bronchopulmonary mycosis research registry
Date of disclosure of the study information 2013/11/01
Last modified on 2021/10/28 (Ver. 9)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Allergic bronchopulmonary mycosis research registry
Acronym ABPM research registry
Scientific Title Allergic bronchopulmonary mycosis research registry
Scientific Title:Acronym ABPM research registry
Region
Japan

Condition
Condition Allergic bronchopulmonary mycosis
Classification by specialty
Pneumology Clinical immunology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Registry and clinical analysis of cases with allergic bronchopulmonary mycosis (ABPM) to establish Japanese guideline of ABPM
Basic objectives2 Others
Basic objectives -Others Observation study of clinical history/QOL/prognosis and accumulation of blood samples from ABPM patients
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes clinical history/QOL/prognosis/fungus-specific antibody in serum/fungi in sputa/et al.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. ABPM or related diseases
A. Allergic bronchopulmonary aspergillosis
B. non-Aspergillus ABPM
C. mucus plug in bronchus
D. bronchocentric granulomatosis
2. controls
E. Aspergilloma
F. severe asthma
G. Healthy subjects
Key exclusion criteria none
Target sample size 370

Research contact person
Name of lead principal investigator
1st name Koichiro
Middle name
Last name Asano
Organization Tokai University School of Medicine
Division name Division of Pulmonary Medicine
Zip code 2591193
Address 143 Shimokasuya, Isehara, Kanagawa
TEL 0463-93-1121
Email ko-asano@tokai-u.jp

Public contact
Name of contact person
1st name Tsuyoshi
Middle name
Last name Oguma
Organization Tokai University School of Medicine
Division name Division of Pulmonary Medicine
Zip code 2591193
Address 143 Shimokasuya, Isehara, Kanagawa
TEL 0463-93-1121
Homepage URL
Email tyoguma@db4.so-net.ne.jp

Sponsor
Institute Japan Agency for Medical Research and Development
Institute
Department

Funding Source
Organization Japan Agency for Medical Research and Development
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Tokai University School of Medicine
Address 143 Shimokasuya, Isehara, Kanagawa
Tel 0463-93-1121
Email tokai-rinsho@ml.tokai-u.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東海大学医学部付属病院(神奈川県)、 国立病院機構相模原病院(神奈川県)、国立病院機構福岡病院(福岡県)、千葉大学真菌医学研究センター(千葉県)、長崎大学病院(長崎県)、北海道大学病院(北海道)、慶應義塾大学病院(東京都)、東邦大学大橋医療センター(東京都)、国立病院機構東京病院(東京都)、埼玉県立循環器呼吸器病センター(埼玉県)

Other administrative information
Date of disclosure of the study information
2013 Year 11 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 250
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2013 Year 10 Month 31 Day
Date of IRB
2013 Year 07 Month 24 Day
Anticipated trial start date
2013 Year 11 Month 01 Day
Last follow-up date
2024 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information prospective registry research

Management information
Registered date
2013 Year 10 Month 22 Day
Last modified on
2021 Year 10 Month 28 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000014136